Mbiotech to distribute Gene Bridges Recombineering Technology in Korea
Advertisement
Gene Bridges GmbH announced that Mbiotech will distribute Gene Bridges' patented Red/ET recombination technology in Korea. Mbiotech was selected due to its expertise producing and marketing a wide range of molecular biology reagents.
Under the terms of the agreement, Mbiotech will be the exclusive source of recombineering kits and reagents for the Korean the biotech community.
Mbiotech is a privately owned manufacturing and distribution company located in Seoul, Korea. The Company specialises in manufacturing a range of products including protein markers, DNA markers, Taq DNA polymerase and Nucleic Acid purification kits. Mbiotech distributes their products worldwide, using a variety of different companies and channels.
Other news from the department business & finance
These products might interest you
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.